| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-70392 | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NBP2-37507-0.025ml | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | AF4654-SP | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2721-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-05409-20ul | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| BSA Free | NB100-2686-0.025mg | |||
![Western Blot: Cdk2 Antibody (2D9) [NBP2-00776] Analysis of extracts (35ug) from 9 different cell lines by using anti-Cdk2 monoclonal antibody.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Western-Blot-NBP2-00776-img0008.jpg "Western Blot: Cdk2 Antibody (2D9) [NBP2-00776] Analysis of extracts (35ug) from 9 different cell lines by using anti-Cdk2 monoclonal antibody.")
![Immunocytochemistry/Immunofluorescence: Cdk2 Antibody (2D9) [NBP2-00776] - Staining of COS7 cells transiently transfected by pCMV6-ENTRY Cdk2.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Immunocytochemistry-Immunofluorescence-NBP2-00776-img0007.jpg)
![Immunohistochemistry-Paraffin: Cdk2 Antibody (2D9) [NBP2-00776] - Staining of paraffin-embedded Carcinoma of Human lung tissue using anti-Cdk2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Immunohistochemistry-Paraffin-NBP2-00776-img0006.jpg)
![Flow Cytometry: Cdk2 Antibody (2D9) [NBP2-00776] - HEK293T cells transfected with either overexpression plasmid (Red) or empty vector control plasmid (Blue) were immunostained by anti-Cdk2 antibody, and then analyzed by flow cytometry.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Flow-Cytometry-NBP2-00776-img0003.jpg)
![Western Blot: Cdk2 Antibody (2D9) [NBP2-00776] - HEK293T cells were transfected with the pCMV6-ENTRY control (Left lane) or pCMV6-ENTRY Cdk2 (Right lane) cDNA for 48 hrs and lysed. Equivalent amounts of cell lysates (5 ug per lane) were separated by SDS-PAGE and immunoblotted with anti-Cdk2.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Western-Blot-NBP2-00776-img0004.jpg)
![Immunocytochemistry/Immunofluorescence: Cdk2 Antibody (2D9) [NBP2-00776] - Immunofluorescent staining of HeLa cells using anti-Cdk2 mouse monoclonal antibody.](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Immunocytochemistry-Immunofluorescence-NBP2-00776-img0005.jpg)
![Flow Cytometry: Cdk2 Antibody (2D9) [NBP2-00776] - Analysis of Hela cells, using anti-Cdk2 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Flow-Cytometry-NBP2-00776-img0001.jpg)
![Flow Cytometry: Cdk2 Antibody (2D9) [NBP2-00776] - Analysis of Jurkat cells, using anti-Cdk2 antibody, (Red), compared to a nonspecific negative control antibody (Blue).](http://images.novusbio.com/fullsize/Cdk2-Antibody-2D9-Flow-Cytometry-NBP2-00776-img0002.jpg)
![Western Blot: CDK2 Antibody (1A6) [NBP2-37507] - Analysis using CDK2 mouse mAb against Jurkat (1), HL-60 (2), K562(3), A431(4), HeLa(5), and NIH3T3 (6) cell lysate.](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Western-Blot-NBP2-37507-img0003.jpg "Western Blot: CDK2 Antibody (1A6) [NBP2-37507] - Analysis using CDK2 mouse mAb against Jurkat (1), HL-60 (2), K562(3), A431(4), HeLa(5), and NIH3T3 (6) cell lysate.")
![Immunocytochemistry/Immunofluorescence: CDK2 Antibody (1A6) [NBP2-37507] - Analysis of HeLa cells using CDK2 mouse mAb (green). Red: Actin filaments have been labeled with Alexa Fluor-555 phalloidin.](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Immunocytochemistry-Immunofluorescence-NBP2-37507-img0004.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (1A6) [NBP2-37507] - Analysis of colon cancer tissues using CDK2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Immunohistochemistry-NBP2-37507-img0007.jpg)
![Flow Cytometry: CDK2 Antibody (1A6) [NBP2-37507] - Analysis of Jurkat cells using CDK2 mouse mAb (green) and negative control (red).](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Flow-Cytometry-NBP2-37507-img0005.jpg)
![Western Blot: CDK2 Antibody (1A6) [NBP2-37507] - Analysis using CDK2 mAb against human CDK2 (AA: 197-295) recombinant protein. (Expected MW is 36.8 kDa)](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Western-Blot-NBP2-37507-img0002.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (1A6) [NBP2-37507] - Analysis of cervical cancer tissues using CDK2 mouse mAb with DAB staining.](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Immunohistochemistry-NBP2-37507-img0006.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (1A6) [NBP2-37507] - Analysis of CDK2 in colon cancer tissue using anti-CDK2 antibody. Image submitted by a verified customer review.](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-Immunohistochemistry-Paraffin-NBP2-37507-img0008.jpg)
![ELISA: CDK2 Antibody (1A6) [NBP2-37507] - Red: Control Antigen (100ng); Purple: Antigen (10ng); Green: Antigen (50ng); Blue: Antigen (100ng);](http://images.novusbio.com/fullsize/CDK2-Antibody-1A6-ELISA-NBP2-37507-img0001.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Analysis in human placenta and kidney tissues using NBP2-88911 antibody. Corresponding CDK2 RNA-seq data are presented for the same tissues.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunohistochemistry-Paraffin-NBP2-88911-img0006.jpg "<b>Orthogonal Strategies Validation. </b>Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Analysis in human placenta and kidney tissues using NBP2-88911 antibody. Corresponding CDK2 RNA-seq data are presented for the same tissues.")
![<b>Orthogonal Strategies Validation. </b>Western Blot: CDK2 Antibody (CL7990) [NBP2-88911] - Analysis in human cell line SK-MEL-30.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Western-Blot-NBP2-88911-img0007.jpg)
![Immunocytochemistry/Immunofluorescence: CDK2 Antibody (CL7990) [NBP2-88911] - Staining of SK-MEL-30 cells using the Anti-CDK2 monoclonal antibody, showing specific staining in the nucleoplasm and cytosol in green. Microtubule- and nuclear probes are visualized in red and blue, respectively (where available).](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunocytochemistry-Immunofluorescence-NBP2-88911-img0001.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Staining of human breast cancer shows moderate to strong nuclear positivity in tumor cells.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunohistochemistry-Paraffin-NBP2-88911-img0002.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Staining of human kidney shows no positivity in cells in tubules as expected.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunohistochemistry-Paraffin-NBP2-88911-img0003.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Staining of human placenta shows strong nuclear positivity in trophoblastic cells.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunohistochemistry-Paraffin-NBP2-88911-img0004.jpg)
![Immunohistochemistry-Paraffin: CDK2 Antibody (CL7990) [NBP2-88911] - Staining of human renal cancer shows moderate to strong nuclear positivity in tumor cells.](http://images.novusbio.com/fullsize/CDK2-Antibody-CL7990-Immunohistochemistry-Paraffin-NBP2-88911-img0005.jpg)
![Western Blot: CDK2 [p Thr160] Antibody [NBP3-13301] - Wild-type (WT) and CDK2 (phospho Thr160) knockout (KO) 293T cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with CDK2 (phospho Thr160) antibody (NBP3-13301) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.](http://images.novusbio.com/fullsize/CDK2-[p-Thr160]-Antibody-Western-Blot-NBP3-13301-img0004.jpg "<b>Genetic Strategies Validation. </b>Western Blot: CDK2 [p Thr160] Antibody [NBP3-13301] - Wild-type (WT) and CDK2 (phospho Thr160) knockout (KO) 293T cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with CDK2 (phospho Thr160) antibody (NBP3-13301) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody, and the signal was developed with Trident ECL plus-Enhanced.")
![<b>Genetic Strategies Validation. </b>Immunohistochemistry-Paraffin: CDK2 [p Thr160] Antibody [NBP3-13301] - CDK2 (phospho Thr160) antibody detects CDK2 (phospho Thr160) protein at cytoplasm and nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human colon. CDK2 (phospho Thr160) stained by CDK2 (phospho Thr160) antibody (NBP3-13301) diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/CDK2-[p-Thr160]-Antibody-Immunohistochemistry-Paraffin-NBP3-13301-img0003.jpg)
![<b>Biological Strategies Validation. </b>Western Blot: CDK2 [p Thr160] Antibody [NBP3-13301] - Untreated (-) and treated (+) HeLa whole cell extracts (30 ug) were separated by 10% SDS-PAGE, and the membrane was blotted with CDK2 (phospho Thr160) antibody (NBP3-13301) diluted at 1:500. The HRP-conjugated anti-rabbit IgG antibody (NBP2-19301) was used to detect the primary antibody.](http://images.novusbio.com/fullsize/CDK2-[p-Thr160]-Antibody-Western-Blot-NBP3-13301-img0001.jpg)
![Immunohistochemistry-Paraffin: CDK2 [p Thr160] Antibody [NBP3-13301] - CDK2 (phospho Thr160) antibody detects CDK2 (phospho Thr160) protein at cytoplasm and nucleus by immunohistochemical analysis. Sample: Paraffin-embedded human colon cancer. CDK2 (phospho Thr160) stained by CDK2 (phospho Thr160) antibody (NBP3-13301) diluted at 1:500. Antigen Retrieval: Citrate buffer, pH 6.0, 15 min](http://images.novusbio.com/fullsize/CDK2-[p-Thr160]-Antibody-Immunohistochemistry-Paraffin-NBP3-13301-img0002.jpg)
![Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-57202317215182.jpg "Western Blot: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Western blot analysis using NBP3-21552 in (1) HeLa treated with AP; (2) HeLa cell lysate.")
![Immunohistochemistry: CDK2 [p Tyr 15] Antibody (SR1560) [NBP3-21552] - Immunohistochemical analysis of paraffin-embedded human bladder cancer, using NBP3-21552.](http://images.novusbio.com/fullsize/nbp3-21552_rabbit-cdk2-p-tyr-15-mab-sr1560-5720231564720.jpg)
![Western Blot: CDK2 Antibody [NBP2-15841] - A. 30 ug 293T whole cell lysate/extract B. 30 ug whole cell lysate/extract of human CD2K-transfected 293T cells 12 % SDS-PAGE CDK2 antibody [N1C3] dilution: 1:5000](http://images.novusbio.com/fullsize/CDK2-Antibody-Western-Blot-NBP2-15841-img0003.jpg "Western Blot: CDK2 Antibody [NBP2-15841] - A. 30 ug 293T whole cell lysate/extract B. 30 ug whole cell lysate/extract of human CD2K-transfected 293T cells 12 % SDS-PAGE CDK2 antibody [N1C3] dilution: 1:5000")
![Knockout Validated: CDK2 Antibody [NBP2-15841] - Wild-type (WT) and CDK2 knockout (KO) 293T cell extracts (30 ug) were separated by 12% SDS-PAGE, and the membrane was blotted with CDK2 antibody diluted at 1:500. HRP-conjugated anti-rabbit IgG antibody was used to detect the primary antibody](http://images.novusbio.com/fullsize/CDK2-Antibody-Western-Blot-NBP2-15841-img0004.jpg)
![Immunohistochemistry-Paraffin: CDK2 [p Thr160] Antibody [NBP3-05409] - Immunohistochemistry of paraffin-embedded human breast carcinoma using CDK2 antibody (NBP3-05409).](http://images.novusbio.com/fullsize/CDK2-[p-Thr160]-Antibody-Immunohistochemistry-Paraffin-NBP3-05409-img0001.jpg "Immunohistochemistry-Paraffin: CDK2 [p Thr160] Antibody [NBP3-05409] - Immunohistochemistry of paraffin-embedded human breast carcinoma using CDK2 antibody (NBP3-05409).")
![Western Blot: CDK2 [p Thr160] Antibody [NBP3-05409] - analysis of C6, using Phospho-CDK2-T160 antibody at 1:400 dilution.Secondary antibody: HRP Goat Anti-Rabbit IgG (H+L) at 1:10000 dilution.Lysates/proteins: 25 ug per lane.Blocking buffer: 3% nonfat dry milk in TBST.Detection: ECL Basic Kit.Exposure time: 90s.](http://images.novusbio.com/fullsize/antibody/nbp3-05409_rabbit-polyclonal-cdk2-p-thr160-antibody-western-blot-159202383355..jpg)
![Immunoprecipitation: CDK2 [p Tyr15] Antibody (2C4) [NBP3-26428] - Immunoprecipitating CDK2 [p Tyr15] in Hela whole cell lysate treated with Pervanadate.Lane 1: Rabbit control IgG (1ug)instead of NBP3-26428 in Hela whole cell lysate treated with Pervanadate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000).Lane 2: NBP3-26428 (3ug) + Hela whole cell lysate treated with Pervanadate (1mg).Lane 3: Hela whole cell lysate treated with Pervanadate (20ug).](http://images.novusbio.com/fullsize/nbp3-26428_rabbit-cdk2-p-tyr-15-mab-2c4-262202413221513.jpg "Immunoprecipitation: CDK2 [p Tyr15] Antibody (2C4) [NBP3-26428] - Immunoprecipitating CDK2 [p Tyr15] in Hela whole cell lysate treated with Pervanadate.Lane 1: Rabbit control IgG (1ug)instead of NBP3-26428 in Hela whole cell lysate treated with Pervanadate. For western blotting, a HRP-conjugated Protein G antibody was used as the secondary antibody (1/2000).Lane 2: NBP3-26428 (3ug) + Hela whole cell lysate treated with Pervanadate (1mg).Lane 3: Hela whole cell lysate treated with Pervanadate (20ug).")
![Western Blot: CDK2 [p Tyr15] Antibody (2C4) [NBP3-26428] - Positive Western Blot detected in: Hela whole cell lysate, 293 whole cell lysate (treated with Pervanadate or not). All lanes: CDK2 [p Tyr15] Antibody at 0.8ug/ml. Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution.Predicted band size: 34 KDaObserved band size: 34 KDa](http://images.novusbio.com/fullsize/nbp3-26428_rabbit-cdk2-p-tyr-15-mab-2c4-28220241140949.jpg)
![Immunocytochemistry/Immunofluorescence: CDK2 [p Tyr15] Antibody (2C4) [NBP3-26428] - Analysis of CDK2 [p Tyr15] Antibody (2C4) diluted at 1:80 and staining in Hela cells (treated with Pervanadate). The cells were fixed in 4% formaldehyde, permeabilized using 0.2% Triton X-100 and blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a biotinylated secondary antibody and visualized using an HRP conjugated SP system.](http://images.novusbio.com/fullsize/nbp3-26428_rabbit-cdk2-p-tyr-15-mab-2c4-28220241312220.jpg)
![Immunohistochemistry: CDK2 Antibody (6A5) [NBP3-26666] - Image of CDK2 Antibody (6A5) diluted at 1:100 and staining in paraffin-embedded human tonsil tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.](http://images.novusbio.com/fullsize/nbp3-26666_rabbit-cdk2-mab-6a5-262202414471566.jpg "Immunohistochemistry: CDK2 Antibody (6A5) [NBP3-26666] - Image of CDK2 Antibody (6A5) diluted at 1:100 and staining in paraffin-embedded human tonsil tissue performed. After dewaxing and hydration, antigen retrieval was mediated by high pressure in a citrate buffer (pH 6.0). Section was blocked with 10% normal goat serum 30min at RT. Then primary antibody (1% BSA) was incubated at 4C overnight. The primary is detected by a Goat anti-rabbit IgG polymer labeled by HRP and visualized using 0.05% DAB.")
![Western Blot: CDK2 Antibody (6A5) [NBP3-26666] - Positive Western Blot detected in: K562 whole cell lysate, HEK293 whole cell lysate, NIH/3T3 whole cell lysate, Hela whole cell lysate, HL-60 whole cell lysate, A549 whole cell lysate. All lanes: CDK2 Antibody at 1: 1000 Secondary: Goat polyclonal to rabbit IgG at 1/50000 dilution. Predicted band size: 34, 31 kDa Observed band size: 34 kDa](http://images.novusbio.com/fullsize/nbp3-26666_rabbit-cdk2-mab-6a5-282202411351622.jpg)